Validose Raises $2M to Combat Clinical Trial Non-Adherence with AI-Powered Medication Delivery
What You Should Know:
– Validose, a 10XBeta Venture Studio portfolio company pioneering precision medication delivery, announced today the successful close of a $2 million pre-seed funding round.
– The round was led by Peter Bauer’s Family Office as part…
Continue Reading